Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1603434

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1603434

Fertility Test Market Size, Share, Growth Analysis, By Product (Ovulation Predictor Kits, Fertility Monitors), By Mode of Purchase (OTC, Prescription), By Application, By End User, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Fertility Test Market size was valued at USD 426.95 million in 2022 and is poised to grow from USD 463.24 million in 2023 to USD 889.7 million by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The fertility test market is poised for significant growth in the upcoming forecast period, propelled by several key factors. Notably, the trend of postponing first pregnancies and an increasing global emphasis on fertility awareness are driving demand for fertility testing solutions. Additionally, declining fertility rates worldwide, combined with the introduction of innovative, user-friendly fertility monitors that boast high accuracy, are key contributors to the market's expansion. The rise of combined testing kits that address both pregnancy and ovulation-particularly in developed countries-is expected to further stimulate market growth. Enhanced healthcare infrastructure investments are also supporting the proliferation of advanced fertility testing products, making them more accessible to consumers. However, challenges remain, including the inconsistent reliability of urine-based ovulation monitors for women with conditions such as PCOS/PCOD, as well as the high costs associated with acquiring these tests, which may deter potential buyers. Overall, while the fertility test market shows promising growth potential driven by demographic trends and technological advancements, addressing accuracy concerns and cost-related barriers will be crucial for maximizing market penetration and fostering consumer trust in these essential health products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Test Market Segmental Analysis

Global Fertility Test Market is segmented by Product, Mode of Purchase, Application, End User and region. Based on Product, the market is segmented into Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood), Male Fertility Testing Products. Based on Mode of Purchase, the market is segmented into OTC based products, Prescription based products, Online products. Based on application, the market is segmented into Female Fertility Products, Male Fertility Products. Based on end user, the market is segmented into home care, Fertility clinics, hospitals, others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Fertility Test Market

The Global Fertility Test market is significantly influenced by the increasing focus on reproductive health, particularly highlighted by the changing demographics of first-time pregnancies. There has been a noteworthy rise in the average age at which women are having their first child, with many women now waiting until 30 or older, as reported by the OECD. This trend has emerged due to a decline in teenage births and reflects a growing preference among women to postpone parenthood. Consequently, the heightened occurrence of first pregnancies among older women is driving demand for fertility-related products and services, propelling the expansion of the market.

Restraints in the Global Fertility Test Market

One significant restraint in the Global Fertility Test market is the limited precision of ovulation prediction kits. These kits function by measuring increases in luteinizing hormone (LH) levels, which typically spike 24-36 hours before ovulation. However, they fall short in reliably confirming ovulation in certain conditions, such as luteinized unruptured follicle syndrome, where the egg remains with the follicle post-LH surge. Additionally, these kits only indicate the onset of ovulation rather than pinpointing the exact timing or accounting for anovulation. The reliance solely on LH detection means they overlook other important markers like fertile cervical mucus, potentially hindering market growth due to their limited accuracy.

Market Trends of the Global Fertility Test Market

The Global Fertility Test market is witnessing a notable trend characterized by the rapid integration of digital health technologies, particularly through the use of smartphones and wearable devices. Fertility tracking apps and advanced ovulation monitors are enabling consumers to monitor their menstrual cycles and fertility metrics with unprecedented convenience. This shift toward digital solutions is transforming traditional fertility testing methodologies, offering users real-time data and personalized insights that foster proactive family planning. As individuals seek more accessible and informed approaches to reproductive health, this trend is likely to drive significant growth in the fertility test market, enhancing user engagement and confidence in their fertility journeys.

Product Code: SQMIG45A2234

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Pricing Analysis

Global Fertility Test Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Testing Products

Global Fertility Test Market Size by Mode of Purchase & CAGR (2024-2031)

  • Market Overview
  • OTC-based products
  • Prescription-based products
  • Online Products

Global Fertility Test Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Female Fertility Products
  • Male Fertility Products

Global Fertility Test Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Home Care Settings
  • Hospitals and Fertility Clinics
  • Other End Users

Global Fertility Test Market Size & CAGR (2024-2031)

  • North America, (Product, Mode of Purchase, Application, End User)
    • US
    • Canada
  • Europe, (Product, Mode of Purchase, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Mode of Purchase, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Mode of Purchase, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Mode of Purchase, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Church & Dwight Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fairhaven Health LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fertility Focus Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geratherm Medical AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiLin Life Products Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prestige Brands Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Swiss Precision Diagnostics GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdvaCare Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Babystart
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioZhena Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Procter & Gamble Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Uebe Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samplytics Technologies Private Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tempdrop LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valley Electronics GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PREGMATE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ava Science Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbot Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!